Vitaquest VMS formulations for minimized nausea
Vitaquest offers VMS tablets, capsules, and powders designed to minimize nausea by protecting sensitive ingredients from stomach acid, releasing nutrients in the intestine. This solution leverages pilot-scale capabilities and regulatory-approved materials for effective delivery.
Overview
Vitaquest VMS formulations are designed to minimize nausea and other stomach-related side effects by encapsulating sensitive ingredients in tablets, capsules, and powders. These formulations protect active ingredients from the acidic environment of the stomach, ensuring nutrients are released effectively in the intestine. This innovative approach addresses common issues associated with VMS (vitamins, minerals, supplements) consumption, enhancing user comfort and compliance.
Technical specifications
Key features:
- Encapsulation of sensitive ingredients to withstand gastric conditions
- Use of regulatory-approved materials for safe and effective delivery
- Pilot-scale capabilities to produce sample VMS tablets, capsules, and powders
- Protection of VMS actives from acidic pH and enzymatic degradation
Applications:
- Suitable for individuals sensitive to conventional VMS formulations
- Applicable in various VMS product forms, including tablets, capsules, and powders
Technology readiness level
This technology is currently at Technology Readiness Level 2. The project involves pilot-scale production trials and plans for commercial-scale trials to validate the hypothesis. The research is expected to take approximately six months, focusing on producing and testing samples to ensure efficacy and safety in minimizing nausea.
About VQ Technologies LLC
VQ Technologies is a wholly owned subsidiary and specialized powder processing facility of Vitaquest International, an industry-leading product development and commercialization partner in the nutraceutical and functional food markets. Acquired in 2023, the facility in Paterson, New Jersey, utilizes advanced fluid bed technology to provide highly specialized capabilities, including granulation, agglomeration, microencapsulation, and liquid and powder blending. This infrastructure allows for application-specific product development and pilot and commercial-scale manufacturing of specialty ingredients, which many companies in the industry otherwise outsource.
By integrating these advanced particle engineering capabilities in-house, VQ Technologies enables Vitaquest to offer its customers enhanced product performance, improved manufacturing efficiency, and faster market entry. The facility supports the development of over 4,000 custom formulas annually for hundreds of brands worldwide, helping partners navigate the entire product lifecycle from concept and formulation to manufacturing and packaging. The acquisition underscores Vitaquest's TotalQ™ commitment to quality and expands its service range, positioning the company as a leader in the dietary supplement and functional food commercialization sector.
delivered to your inbox.